Understanding the kinomic contributions to tyrosine kinase inhibitor resistance in triple negative breast cancer

被引：0
|
作者：
Lefebvre, Cory [1 ]
Litchfield, David [1 ]
Allan, Alison [1 ]
机构：
[1] Western Univ, London, ON, Canada
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-1282
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1282
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mechanisms of acquired resistance to c-Src kinase inhibitor in triple negative breast cancer
    Gilani, Rabia A.
    Lachacz, Eric J.
    Phadke, Sameer
    Bao, Li Wei
    Cheng, Xu
    Jiagge, Evelyn M.
    Soellner, Matthew B.
    Merajver, Sofia D.
    [J]. CANCER RESEARCH, 2017, 77
  • [2] Mechanism of MEK inhibitor resistance in triple negative breast cancer
    Gagliardi, Maria
    Tacam, Moises
    Iles, Lakesla
    Qi, Yuan
    Pusztai, Lajos
    Tripathy, Debu
    Bartholomeusz, Geoffrey
    Bartholomeusz, Chandra
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [3] GLPG1790: The first Ephrin (EPH) receptor tyrosine kinase inhibitor for the treatment of triple negative breast cancer
    Pujuguet, Philippe
    Beirinckx, Filip
    Delachaume, Carole
    Huck, Jacques
    Van der Aar, Ellen
    Brys, Reginald
    Van Rompaey, Luc
    Wigerinck, Piet
    Saniere, Laurent
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [4] Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
    Jichao He
    Ronan P. McLaughlin
    Vera van der Noord
    John A. Foekens
    John W. M. Martens
    Gerard van Westen
    Yinghui Zhang
    Bob van de Water
    [J]. Breast Cancer Research and Treatment, 2019, 178 : 263 - 274
  • [5] Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
    He, Jichao
    McLaughlin, Ronan P.
    van der Noord, Vera
    Foekens, John A.
    Martens, John W. M.
    van Westen, Gerard
    Zhang, Yinghui
    van de Water, Bob
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (02) : 263 - 274
  • [6] NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer
    Darvishi, Behrad
    Farahmand, Leila
    Eslami-S, Zahra
    Majidzadeh-A, Keivan
    [J]. TUMOR BIOLOGY, 2017, 39 (06) : 1 - 10
  • [7] The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells
    Chun-Yu Liu
    Tzu-Ting Huang
    Pei-Yi Chu
    Chun-Teng Huang
    Chia-Han Lee
    Wan-Lun Wang
    Ka-Yi Lau
    Wen-Chun Tsai
    Tzu-I Chao
    Jung-Chen Su
    Ming-Huang Chen
    Chung-Wai Shiau
    Ling-Ming Tseng
    Kuen-Feng Chen
    [J]. Experimental & Molecular Medicine, 2017, 49 : e366 - e366
  • [8] The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells
    Liu, Chun-Yu
    Huang, Tzu-Ting
    Chu, Pei-Yi
    Huang, Chun-Teng
    Lee, Chia-Han
    Wang, Wan-Lun
    Lau, Ka-Yi
    Tsai, Wen-Chun
    Chao, Tzu-I
    Su, Jung-Chen
    Chen, Ming-Huang
    Shiau, Chung-Wai
    Tseng, Ling-Ming
    Chen, Kuen-Feng
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2017, 49 : e366 - e366
  • [9] Triple-negative breast cancer: understanding Wnt signaling in drug resistance
    Parnaz Merikhian
    Mohammad Reza Eisavand
    Leila Farahmand
    [J]. Cancer Cell International, 21
  • [10] Triple-negative breast cancer: understanding Wnt signaling in drug resistance
    Merikhian, Parnaz
    Eisavand, Mohammad Reza
    Farahmand, Leila
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)
12345